Approvals/TGA/ZolaCos CP Combination Goserelin 10.8mg (as Acetate) Implant Syringe and Bicalutamide 50mg tablet blister pack

Approved

STANDARD

ZolaCos CP Combination Goserelin 10.8mg (as Acetate) Implant Syringe and Bicalutamide 50mg tablet blister pack

AstraZeneca Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 9bd71eeb8839dd77
Product Name: ZolaCos CP Combination Goserelin 10.8mg (as Acetate) Implant Syringe and Bicalutamide 50mg tablet blister pack
Artg Id: 125687
Artg Name: ZolaCos CP combination Goserelin 10.8mg (as Acetate) Implant Syringe and Bicalutamide 50mg tablet blister pack
Sponsor: AstraZeneca Pty Ltd
Company Detail Path: /organization/astrazeneca-pty-ltd
Artg Date: 2006-12-01
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/1441b0f647b010f95a59e5d6abebc024.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/d6e5f240bc020cf2cf98d62e62b13039.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

9bd71eeb8839dd77

Type

Standard